Comparación de protocolos de vacunación contra el virus del papiloma humano en Ecuador y América Latina

Abstract

The Human Papilloma Virus is a sexual transmission infection with more than 100 variants The Drugs and Food Administration of the USA, approved in 2006 the first quadrivalent vaccine and in 2014 the nonavalent vaccine was admitted. Many Latín American countries have introduced the vaccines against the Human Papilloma Virus. Although Latín América is the región which advanced faster against the Human Papilloma Virus, its survelliance and follow Up systems are yet deficient. The objective of the review is to compare the different strategies to assume the vaccination against the Human Papilloma Virus in Ecuador and Latin America. The information was obtained from government documents and articles indexed in the last 5 years. Most Latín American countries have managed to introduce the vaccine against the Human Papilloma Virus, except Venezuela, Martinica, Haiti, Nicaragua and Cuba. The vaccination protoccols of Ecuador and Latín América need yo improve their systems of follow Up and monitoring, and increase the expansión of available data in a consistent manner for this vaccine. Recently, there are still existing challenges to introduce the vaccines, manage a high reach and fortify the follow Up, the evaluation and the notification